Forbion raises record €2.3bn across latest biotech venture, growth funds
Tuesday, October 6, 2026 · first reported by AltAssets and 3 others
Forbion closes dual fundraise at €2.3bn (~$2.53bn), exceeding predecessor fund size, backed by institutional LPs.
- Firm
- Forbion
- Size
- $2.5B
- Stage
- Final close
- Asset class
- Venture
- Geography
- Europe
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
4 sources- AltAssetsForbion raises record €2.3bn across latest biotech venture, growth funds
- Alternatives WatchForbion tops predecessor haul with €2.3bn dual fundraise
- BioSpaceBiotech VC Forbion raises record $2.6B to support 30 ‘high-potential’ companies
- Investors in HealthcareNetherlands: Forbion raises €2.3bn across two new life sciences venture funds
- Sheridan closes $1.1bn Fund IV, adds $245m healthcare IT vehicleAlternatives Watch
- Niobrara Capital closes inaugural fund with more than $1.5bn in commitmentsPrivate Equity Wire +4
- Dig’s new fund bets on infrastructure built around foundation modelsVenture Capital Journal
- Linse Capital moves into early-stage deep tech with $150m Ignition strategyAltAssets
- NVM Ventures launches with €23.6M first close for dual-use startupsDealroom +3
- Venture Capital: Cypress Asia launches RM50 mil debut venture fund with New Hoong Fatt as anchor investortheedgemalaysia.com +2